1. Andreeva, L.A., Myasoedov, N.F., Lyapina, L.A., et al., Effect of the Pro-Gly-Pro peptide on hemostasis and lipid metabolism in rats with hypercholesterolemia, Dok. Biol. Sci, 2013, vol. 453, pp. 333–335.
2. Cojocaru, E., Zamfir, C., Zamosteanu, N., et al., The effects of branched chain aminoacids on hdl-cholesterol in experimental animals subjected to dietary hypercholesterolemia, Rev. Med. Chir. Soc. Med. Nat. Iasi., 2012, vol. 116, no. 1, pp. 200–206.
3. Colley, K.J., Wolfert, R.L., and Cobble, M., Lipoprotein-associated phospholipase A2 in atherosclerosis and its suitability for use as a biomarker of risk for cardiovascular disease, Ateroskleroz Dislipidemii, 2011, no. 3, pp. 1–4.
4. Gerber, Y., Dunlay, S.M., Jaffe, A.S., et al., Plasma lipoprotein-associated phospholipase A2 levels in heart failure: association with mortality in the community, Atherosclerosis, 2009, vol. 203, no. 2, pp. 593–598.
5. Kudrjashov, B.A. and Lyapina, L.A., Nonenzymatic fibrinolysis and its role in the organism, in Thrombosis and Thrombolysis, Chazov, E.I. and Smirnov, V.N., Eds., New York: Consultants Bureau, 1986, pp. 33–65.